FDA panel backs Alzheimer's drug that can reportedly slow cognitive decline
Interactive Video
•
Health Sciences, Biology
•
University
•
Hard
Wayground Content
FREE Resource
The FDA has approved a new medication aimed at slowing the effects of Alzheimer's disease. An advisor claims the drug's benefits outweigh its risks, potentially delaying cognitive decline by several months. However, experts are divided on whether patients or their families will notice a significant difference.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What are the risks associated with the new Alzheimer's medication?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
In what ways might the new medication impact patients and their loved ones?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
